Covered recipient · General Payments record
JOHN LYON
General Payments · PY2019–2024
$1,678.64
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $472.99 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $140.26 | 8 |
| Bausch & Lomb Americas Inc. | $116.30 | 2 |
| Astellas Pharma US Inc | $90.56 | 3 |
| Ocular Therapeutix, Inc. | $65.52 | 3 |
| Alcon Laboratories Inc | $60.35 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.73 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916125 | CMS |
| ABBVIE INC. | $29.73 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916127 | CMS |
| ABBVIE INC. | $2.37 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916129 | CMS |
| ABBVIE INC. | $25.93 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916131 | CMS |
| ABBVIE INC. | $9.79 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916133 | CMS |
| ABBVIE INC. | $9.43 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916135 | CMS |
| ABBVIE INC. | $14.46 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916137 | CMS |
| ABBVIE INC. | $22.82 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104916139 | CMS |
| Alcon Vision LLC | $23.29 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110587121 | CMS |
| Alcon Vision LLC | $18.76 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110587119 | CMS |
| Alcon Vision LLC | $18.30 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110587117 | CMS |
| Astellas Pharma US Inc | $30.97 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139321270 | CMS |
| Astellas Pharma US Inc | $25.52 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139321598 | CMS |
| Astellas Pharma US Inc | $34.07 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139321266 | CMS |
| Bausch & Lomb Americas Inc. | $19.80 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140373629 | CMS |
| Bausch & Lomb Americas Inc. | $96.50 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140373627 | CMS |
| Ocular Therapeutix, Inc. | $22.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148199915 | CMS |
| Ocular Therapeutix, Inc. | $21.63 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148199919 | CMS |
| Ocular Therapeutix, Inc. | $21.14 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148199917 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.